Therapy resistant major depression: Symptom improvement after psychopharmacological combination of antidepressants and methylphenidate;Therapieresistente depression: Symptombesserung nach kombinationstherapie mit antidepressiva und methylphenidat

Wiener Medizinische Wochenschrift

Volumn 152, Issue 21-22, 2002, Pages 578-580

  Niederhofer, Helmut ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Combination of antidepressants and methylphenidate; Therapy resistant depression

Indexed keywords

ANTIDEPRESSANT AGENT; METHYLPHENIDATE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR DEPRESSION; NARCOLEPSY; PSYCHOPHARMACOLOGY; DRUG COMBINATION; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHYLPHENIDATE; TREATMENT OUTCOME;

EID: 0036025410     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-258X.2002.01066.x     Document Type: Article

References (25)

1. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV: Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Paediatrics 1999:104:20.
2. Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M: Pemoline treatment of adolescents with attention deficit hyperactivity disorder: A short-term controlled trial. J Child Adolesc Psychopharmacol 2000;10:205-216.
3. Bruun RD, Budman CL: Paroxetine treatment of episodic rages associated with Tourette's disorder. J Clin Psychiatry 1998:59:581-584.
4. Ernst M, Liebenauer LL, Jons PH, Tebeka D, Cohen RM, Zametkin AJ: Selegiline in adults with attention deficit hyperactivity disorder: Clinical efficiacy and safety. Psychopharmacol Bull 1996;32:327-334.
5. Feifel D: Attention-deficit hyperactivity disorders in adults. Postgrad Med 1996:100:215-218.
6. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, Spencer TJ, Wilens TE, Frazier J, Cleves M, Sakai J: Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 1999:156:768-770.
7. Hollander E, Kaplyn A, Cartwright C, Reichman D: Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: An open retrospective clinical report. J Child Neurol 2000; 15:132-135.
8. Hornyak JE, Nelson VS, Hurvitz EA: The use of methylphenidate in paediatric traumatic brain injury. Paediatr Rehabil 1997; 1:15-17.
9. Horrigan JP, Barnhill LJ: Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 2000:61:414-417.
10. Kessler S: Drug therapy in attention-deficit hyperactivity disorder. South Med J 1996:89:33-38.
11. Kompoliti K, Goetz CG: Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mor Disord 1998:13:477-480.
12. Kotler M, Manor I, Sever Y, Eisenberg J, Cohen H, Ebstein RP, Tyano S: Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family based study. Am J Med Genet 2000:96:278-281.
13. Krause KH, Dresel, SH, Krause, J, Kung, HF, Tatsch, K: Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000;285:107-110.
14. Muglia P, Jain U, Macciardi F, Kennedy JL: Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 2000:96:273-277.
15. Riederer P, Laux G, Pöldinger W (eds): Neuropsychopharmaka. New York. Springer. 1992.
16. Sachdev PS, Trollor JN: How high a dose of stimulant medication in adult attention deficit hyperactivity disorder? Aust N Z J Psychiatry 2000:34:645-650.
17. Schulz KP, McKay KE, Newcorn JH, Sharma V, Gabriel S, Halperin JM: Serotonin function and risk for alcoholism in boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology 1998;18;10-17.
18. Searight HR, Burke JM, Rottnek F: Adult ADHD: Evaluation and treatment in family medicine. Am Fam Physician 2000;62:2077-2086.
19. Steinhausen, HC: Hyperkinetische Störungen im Kindes- und Jugendalter. Stuttgart. Kohlhammer. 1995.
20. Sunshine JL, Lewin JS, Wu DH, Miller DA, Findling, RL, Manos MJ, Schwartz, MA: Functional MR to localize sustained visual attention activation in patients with attention deficit hyperactivity disorder: a pilot study. Am J Neuroradiol 1997;18:633,637.
21. Valentine J, Rossi E, O'Leary P, Parry TS, Kurinczuk JJ, Sly P: Thyroid function in a population of children with attention deficit hyperactivity disorder. J Paediatr Child Health 1997;33:117-120.
22. Wender PH: Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 1998;59(Suppl):76-79.
23. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D: Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1147-1153.
24. Wilens TE, Biederman J, Gesit DE, Steingard R, Spencer T: Nortryptiline in the treatment of ADHD: A chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 1993;32:343-349.
25. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, Yamada EM, Cohen RM: Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50:333-340.